Gilead Sciences (GILD) PT Raised to $123 at RBC Capital
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $144.69 +0.67%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 48
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 48
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $123.00 (from $120.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Enbridge Inc. (ENB:CN) (ENB) PT Raised to Cdn$80 at Raymond James
- Aveanna Healthcare Holdings Inc (AVAH) PT Raised to $15 at JPMorgan
- Delek US (DK) PT Raised to $81 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
